Challenges in Perioperative Fluid Management and Anticoagulant Therapy in a Woman with Cardio-Pulmonary-Renal Disease Diagnosed with Preinvasive Breast Carcinoma
Perioperative Fluid and Anti-coagulant Therapy
Vol. 18 No. 1 : 2023 (272-278)
Abstract
An elderly woman with preinvasive breast cancer, atrial fibrillation, coronary artery-pulmonary artery fistula, pulmonary hypertension and Stage 4 diabetic nephropathy underwent a mastectomy and sentinel lymph node biopsy. Managing her perioperative fluid balance and anticoagulation treatment were challenging. Having a malignancy, atrial fibrillation plus underhydration will increase her risk of hypercoagulation. However, fluid overload will lead to pulmonary oedema which will decrease her oxygenation further in pulmonary hypertension. Cessation of anticoagulation also increased the risk of hypercoagulation. Anticoagulant therapy increases the risk of a perioperative wound haematoma, which may require another general anaesthesia for identification and arrest of the bleeding source and haematoma evacuation. A haematoma will also increase the risk of surgical site infection; especially as a diabetic. Her anticoagulant therapy (rivoroxaban) was stopped four days preoperatively. Her ejection fraction was 50%, with Grade II diastolic dysfunction and TAPSE 0.6 cm. Her CHA2DS2-VASc Score was 5. Perioperatively, intraarterial cannulation was connected to the FloTrac™ sensor and EV1000™ monitor. Her fluid management was monitored using goal directed (GD) fluid therapy. The patient underwent surgery successfully and her anticoagulant therapy was recommenced 14 days postoperatively.
Keywords :
atrial fibrillation,
Breast cancer,
haematoma,
hypercoagulation,
mastectomy,
nephropathy,
pulmonary hypertension,
Correspondance Address
Professor Dr. Norlia Abdullah. Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. Tel: +603-9145 5795 Email: norlia@ppukm.ukm.edu.my
References
Al Rasyid, Harris, S., Kurniawan, M., Mesiano, T., Hidayat, R., Meisadona, G. 2019. Blood viscosity as a determining factor of ischemic stroke outcomes evaluated with NIHSS and MRS on Day 7 and 30 post-thrombolysis. Int J Pharm Pharm Sci 11(9): 73-9.
Angappan, S., Parida S., Vasudevan A., Badhe, A. 2005. The comparison of stroke volume variation with central venous pressure in predicting fluid responsiveness in septic patients with acute circulatory failure. Indian J Crit Care Med 19(7): 394-400.
Corcoran, T., Rhodes, J.E., Clarke, S., Myles, P.S., Ho, K.M. 2012. Perioperative fluid management strategies in major surgery: a stratified meta-analysis; Anesth Analg 114(13): 640-51.
Dardiotis, E., Aloizou, A-M., Markoula, S., Siokas, V., Tsarouhas, K., Tzanakakis, G., Libra, M., Kyritsis, A.P., Brotis, A.G., Aschner, M., Gozes, I., Bogdanos, D.P., Spandidos, D.A., Mitsias, P.D., Tsatsakis, A. 2019. Cancer-associated stroke: Pathophysiology, detection and management (Review). Int J Oncol 54(3): 779-96.
Douketis, J.D., Lip, G.Y.H. Perioperative management of patients receiving anticoagulants. 2019. https://www.uptodate.com/contents/perioperative-management-of-patients-receiving-anticoagulants/print [1 September 2021].
Galie`, N., Hoeper, M.M., Humbert, M., Torbicki, A., Vachiery, JL., Barbera, J.A., Beghetti, M., Corris, P., Gaine, S., Gibbs, J.S., Gomez-Sanchez, M.A., Jondeau, G., Klepetko, W., Opitz, C., Peacock, A., Rubin, L., Zellweger, M., Simonneau, G. 2009. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34(6): 1219-63.
Giglio, M.T., Marucci, M., Testini, M., Brienza, N. 2009. Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: A meta-analysis of randomized controlled trials. Br J Anaesth 103(5): 637-46.
Hemmingsen, M.N., Larsen, A., Ørholt, M., Rasmussen, L.E., Weltz, T.K., Andersen, P.S., Sarmady, F.N., Elberg, J.J., Vester-Glowinski, P.V., Herly, M. 2022. Hematoma and deep surgical site infection following primary breast augmentation: A retrospective patients. J Plast Reconstr Aesthet Surg 75(3): 1197-203.
Jansen Pharmaceuticals. https://www.xareltohcp.com/treatment-considerations [29 September 2021].
Klabunde, R.E. 2022. The pharmacologic treatment of pulmonary hypertension. https://www.cvpharmacology.com/clinical%20topics/pulmonary%20hypertension#:~:text=Normally%2C%20mean%20pulmonary%20arterial%20pressure,pressure%20is%20about%208%20mmHg. [26 September 2021].
Lobo, D.N., Bostock, K.A., Neal, K.R., Perkins, A.C., Rowlands, B.J., Allison, S.P. 2002. Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: A randomised controlled trial. Lancet 359(9320): 1812-8.
Nisanevich, V., Felsenstein, I., Almogy, G., Weissman, C., Einav, S., Matot, I. 2005. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 103(1): 25-32.
Olesen, J.B., Torp-Pedersen, C., Hansen, M.L., Lip, G.Y. 2012. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost 107(6): 1172-9.
Pani, N., Dongare, P.A., Mishra, R.K. 2015. Reversal agents in anaesthesia and critical care. Indian J Anaesth 59(10): 664-9.
Pritts, C.D., Pearl, R.G. 2010. Anesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol 23(3): 411-6.
Salemis, N.S. 2017. Rivaroxaban-induced chest wall spontaneous expanding hematoma. Drug Discov Ther 11(1): 47-50.
Song, J., Tark, A., Larson, E.L. 2020. The relationship between pocket hematoma and risk of wound infection among patients with a cardiovascular implantable electronic device: An integrative review. Heart Lung 49(1): 92-8.
Vincent, JL., Pelosi, P., Pearse, R., Payen, D., Perel, A., Hoeft, A., Romagnoli, S., Ranieri, V.M., ,Ichai, C., Forget, P., Della Rocca, G., Rhodes, A. 2015. Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12. Crit Care 19(1): 224.
